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Background: Research studies to inform clinical practice and policy in children and young people with
appendicitis are hampered by inconsistent selection and reporting of outcomes. The aim of this study was
to develop a core outcome set for reporting all studies of uncomplicated acute appendicitis in children
and young people.
Methods: Systematic literature reviews, qualitative interviews with parents and patients treated for
uncomplicated acute appendicitis, and a Study-Specific Advisory Group informed a long list of outcomes.
Outcomes were then prioritized by stakeholders based in the UK (patients, parents, and paediatric
and general surgeons) in an online three-round Delphi consensus process, followed by face-to-face
consensus meetings.
Results: A long list of 40 items was scored by 147 key stakeholders in the first Delphi round, of whom
90 completed the two subsequent Delphi rounds. The final core outcome set comprises 14 outcomes:
intra-abdominal abscess, reoperation (including interventional radiology procedure), readmission to hos-
pital, bowel obstruction, wound infection, antibiotic failure, wound complication, negative appendicec-
tomy, recurrent appendicitis, death, patient stress/psychological distress, length of hospital stay, time
away from full activity and child’s quality of life.
Conclusion: A core outcome set comprising 14 outcomes across five key domains has been developed
for reporting studies in children and young people with uncomplicated acute appendicitis. Further work
is required to determine how and when to measure these outcomes.
∗Members of the Appendicitis Core Outcome Set Study Group are co-authors of this article and can be found under
the heading Collaborators
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Introduction
Acute appendicitis is the most common surgical emergency
in children and young people1. A systematic review2 of
outcomes reported in RCTs and meta-analyses of acute
appendicitis in children revealed wide heterogeneity in
outcome selection. Such differences make it challeng-
ing, sometimes impossible, to synthesize study results
and conduct meta-analyses. Standardizing outcomes by
developing and implementing a core outcome set facilitates
data synthesis, and ensures that outcomes of importance
to relevant stakeholders are included. This study aimed
to develop a core outcome set for future research on
operative and non-operative treatments for uncomplicated
acute appendicitis in children and young people (aged less
than 18 years).
© 2020 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. BJS
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Methods
The study adopted established consensus methods3,
involving three phases: phase 1, development of a long
list of outcomes using systematic reviews and qualitative
interviews with patients and parents; phase 2, a three-round
online Delphi survey with key stakeholders (patients, par-
ents, and paediatric and general surgeons); and phase 3,
two consensus meetings. The recommended core out-
come set development standards were met when planning,
conducting and reporting the project4,5. The study was
part of the CONservative TReatment of Appendicitis
in Children – a randomized controlled Trial (CON-
TRACT) feasibility study6 which received research ethical
approval (South Central – Hampshire A Research Ethics
Committee, 16/SC/0596).
A Study-Specific Advisory Group (SSAG) comprising
children, young people and parents, which was assem-
bled for the CONTRACT feasibility study7, informed the
development of study materials and a participant video8.
Some members also attended the patient and parent con-
sensus meeting to facilitate discussion. The study protocol
has been published elsewhere9 and was registered with the
COMET (Core Outcome Measures in Effectiveness Tri-
als) Initiative in May 201710.
Scope of the core outcome set
The core outcome set is intended for use in future research
(including clinical trials) that evaluates the overall success
of operative or non-operative (antibiotics) treatment in
children and young people aged less than 18 years with
uncomplicated acute appendicitis.
Phase 1: developing a long list of outcomes
A long list of outcomes was developed from two sources:
first, from recent systematic literature reviews2,11 to iden-
tify previously reported outcomes in trials examining the
treatment of uncomplicated acute appendicitis in children
and young people; and, second, from the CONTRACT
communication study embedded within the CONTRACT
feasibility study. This involved semistructured qualitative
interviews with patients and parents who participated in
the CONTRACT feasibility study7 to explore which out-
comes were important to them. Researchers subsequently
mapped outcomes identified from the qualitative study to
outcomes identified from the literature reviews to deter-
mine whether there were any additional outcomes. This
long list was then refined to avoid duplication. Members
of the SSAG were presented with draft text, including out-
come names and descriptions, and instructions on outcome
scoring, for the Delphi survey website. The group was
asked to annotate and discuss the text and design on the
Delphi website to improve clarity and comprehensibility.
Additional outcomes suggested by the SSAG were also con-
sidered for inclusion. The group’s feedback was used to
revise the Delphi website before invitations were sent to
potential participants.
Phase 2: three-round online Delphi survey
A three-round online Delphi survey was used to develop
the core outcome set.
Stakeholder identification
Stakeholders were separated into three panels: patients;
parents; and paediatric or general surgeons who treat
children with appendicitis. Patients (aged 12–18 years)
and parents of patients (aged 5–18 years), who had either
received treatment or whose children had received treat-
ment for uncomplicated acute appendicitis in the preceding
24 months, were invited to participate at seven specialist
children’s hospitals, across five geographical regions in
England.
Paediatric surgeons in the UK who treat children with
uncomplicated acute appendicitis were invited to par-
ticipate via the membership list of the British Associ-
ation of Paediatric Surgeons (including consultants and
trainees), and through professional contacts of the investi-
gators. General surgeons who regularly treat children with
uncomplicated acute appendicitis were invited to partici-
pate via the Association of Surgeons of Great Britain and
Ireland, existing professional contacts and regional surgical
networks in the UK.
Stakeholders from outside the UK were not invited as
this would have posed logistical and resource challenges
given that the intention was to include patients, parents and
surgeons3.
Stakeholder registration
Stakeholders received an invitation letter and information
sheet with a link to a study website, allowing them to access
further information, view the study video and register.
Registration was open for approximately 10 weeks until the
desired number of stakeholders had registered (minimum
10 per panel). The aim was to have 75–100 stakeholders
in the Delphi first round with equal numbers in each
stakeholder panel12.
Delphi surveys
An online three-round Delphi survey was carried out in
parallel across all stakeholder panels. Software developed
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by the National Perinatal Epidemiology Unit (University
of Oxford, Oxford, UK), which had been used successfully
to develop two paediatric surgical core outcome sets13,14,
was hosted on a secure server.
Stakeholders were presented with the long list of out-
comes arranged into themes. In all three Delphi rounds,
stakeholders were asked to score each outcome using
the GRADE (Grading of Recommendations, Assessment
Development and Evaluations) scale, which is commonly
used in the development of core outcome sets. The scale
allows stakeholders to score the importance of each out-
come from 1 to 9 as follows: 1–3, not important; 4–6,
important but not critical; and 7–9, critical for inclusion
in a core outcome set15. Stakeholders could propose other
outcomes at the end of the round 1 survey. These were
reviewed and mapped to the existing long list, if appropri-
ate. New outcomes were added to the long list in round 2
if: members of the study team were not in agreement that
the outcome could be mapped to one on the existing long
list; they were defined as an outcome3; and were proposed
by at least two stakeholders.
All stakeholders who completed each round were invited
to participate in the subsequent round. Participants were
provided with feedback from their own stakeholder panel
in round 2, and from all stakeholder panels in round 3, in
order to build consensus between stakeholder panels and
then across panels14.
Scores for each outcome were analysed for each stake-
holder panel and descriptive statistics generated at the end
of each round. In accordance with the GRADE scoring sys-
tem, the consensus status of each outcome was defined at
the end of each round. The status was ‘consensus in’ when
at least 70 per cent of stakeholders rated the outcome 7–9,
and less than 15 per cent rated it as 1–3; ‘consensus out’
when at least 70 per cent of stakeholders rated the outcome
1–3 and less than 15 per cent rated it 7–9; and ‘no con-
sensus’ if the outcome did not meet the criteria for either
‘consensus in’ or ‘consensus out’.
In round 2, all stakeholders were asked to rescore each
outcome, taking into account how others in their stake-
holder panel had scored the outcome. Stakeholders were
also asked to score any new outcomes.
In round 3, attrition was noted among the patient panel.
As the aim was to ensure that the final core outcome set
represented the views of children and young people, in
addition to parents and surgeons, all patients who com-
pleted round 1 were invited to participate in round 3. All
stakeholders were again asked to rescore each outcome,
taking into account how others in their panel and stake-
holders in the other two panels had scored the outcome
in round 2.
Phase 3: consensus meetings
The study team e-mailed surgeons and parents who com-
pleted all three rounds of the Delphi survey, together with
all patients who had registered for the study (to increase
patient representation), to invite them to attend a consen-
sus meeting in Birmingham, UK, in June 2018. However,
far fewer stakeholders were able to attend than anticipated,
so the study team agreed to postpone the consensus meet-
ing. Following consultation with stakeholders, the team
held two separate consensus meetings. Although this devi-
ated from the study protocol, other core outcome set devel-
opers have used this approach, and have suggested that
holding separate meetings for patients and health profes-
sionals may help avoid the risk that meetings are dominated
by health professionals16. The surgeon consensus meet-
ing was held in September 2018 in London, and the par-
ent and patient consensus meeting in September 2018 in
Birmingham.
All attendees were sent a consensus meeting booklet
describing the study aims, purpose of the consensus meet-
ings, and an overview of the Delphi results. A chair-
person was selected for each meeting with expertise in
core outcome set development to promote and poten-
tially mediate discussion. The Patient and Public Involve-
ment Lead for the CONTRACT feasibility study and
two families from the SSAG also attended the parent and
patient consensus meeting to help facilitate discussion,
but did not vote. The meetings included an overview of
the study so far, instructions for the meeting, discussion
of outcomes and anonymous voting using TurningPoint
electronic software (Turning Technologies, Youngstown,
Ohio, USA).
Owing to attrition (particularly among patients) and
potential response bias, the study team prioritized which
outcomes to discuss and rescore in the meetings, rather
than rescoring all outcomes as proposed previously9. Brief
discussion took place for outcomes where at least 70
per cent of stakeholders across all panels rated the out-
come 7–9. After discussion, the Chair asked stakehold-
ers whether they felt that any of these outcomes should
be excluded from the final core outcome set, and out-
comes were rescored only if stakeholders voiced a prefer-
ence to revote. Again, brief discussion took place for out-
comes where less than 50 per cent of stakeholders across
all stakeholder panels rated the outcome 7–9 at the end
of the third Delphi round, with an option to rescore if
stakeholders voiced a preference to revote. All other out-
comes (those scored 7–9 by 50–69 per cent of stakehold-
ers) were presented, discussed and rescored, unless stake-
holders felt strongly that, following discussion, rescoring
was unnecessary. After discussion and rescoring, outcomes
© 2020 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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reaching ‘consensus in’ at either meeting were included
in the final core outcome set, in line with previous stud-
ies with a similar design16,17. All other outcomes were
excluded.
Data analysis
Descriptive statistics were used to calculate the scores
for each outcome, which were analysed in total and for
each stakeholder panel, at each round. The data ana-
lysis process from round 1 was repeated for rounds 2
and 3. The study team included partial respondents in
the analysis, and examined graphically whether attrition
had an effect on outcome scores, as recommended in the
COMET Handbook3, and using a multilevel modelling
approach (level 1: outcome; level 2: participant; level 3:
stakeholder panel) employing MLwiN version 3.01 (Cen-
tre for Multilevel Modelling, University of Bristol, Bris-
tol, UK). Results are shown as estimates with standard
deviations.
Results
Phase 1: developing a long list of outcomes
The qualitative team identified eight outcomes of impor-
tance to families, and all of these mapped to outcomes
already identified from the reviews (Table S1, supporting
information). Thus no new outcomes were revealed and
a long list of 40 outcomes was generated (Table S2, sup-
porting information) and categorized into themes: out-
comes during an operation (if performed); outcomes that
may occur after treatment; duration of recovery; additional
(unplanned) procedures during the first hospital admission;
outcomes related to pain; other complications; outcomes
reported by patients; cost of treatment and resources used;
and other outcomes.
Phase 2: three-round online Delphi surveys
Between October and December 2017, 818 parents and
patients from seven National Health Service sites in Eng-
land were invited to participate in the study. It was not
possible precisely to measure the number of paediatric and
general surgeons who were invited to participate.
Overall, 195 stakeholders were registered (15 patients, 67
parents, 57 paediatric surgeons and 56 general surgeons)
(Fig. 1). The median ages of patients who registered and
completed rounds 1, 2 and 3 were 12⋅5 (range 11–18), 13⋅5
(11–18), 12 (12–14) and 14 years respectively. The median
age of patients of parents who registered and completed
rounds 1– 3 was 10 (3–18) years throughout.
Twenty-six stakeholders in round 1 proposed 35 addi-
tional outcomes (Table S3, supporting information), of
which three were agreed to be new and included in subse-
quent rounds: psychological distress, negative appendicec-
tomy and time to normal diet.
None of the outcomes were voted ‘consensus out’ in any
of the Delphi rounds. Outcome scores across each round
are summarized in Table 1, and outcome scores for each
stakeholder panel by Delphi round are shown in Tables
S4–S6 (supporting information). Attrition analysis indi-
cated no systematic significant difference in responders and
non-responders between rounds 1 and 2, and rounds 1
and 3. On average, round 1 scores were 6⋅1(s.d. 0⋅2) for
those who completed round 1 only, and were increased
by 0⋅1(0⋅2) among those who also completed round 2
(P = 0⋅609); round 1 scores were increased by 0⋅1(0⋅3)
among those who also completed round 3 (P = 0⋅603).
Median scores for individual items, and score frequency
distributions were also similar between responders and
non-responders (Tables S7 and S8, Figs S1 and S2, support-
ing information).
Phase 3: consensus meetings
Overall, 28 stakeholders participated in the consensus
meetings (Fig. 1).
Surgeon consensus meeting
Ten paediatric and seven general surgeons attended. Dur-
ing the meeting, several outcomes warranted extended
discussion and/or a second vote. Some were outcomes
that were not voted ‘consensus in’ in round 3 of the
Delphi survey but which surgeons felt strongly were
important to include in the core outcome set: negative
appendicectomy, time away from full activity, length of
hospital stay, and wound infection. Following discussion
and voting, surgeons reached consensus to include these
outcomes.
Other outcomes that were discussed had reached ‘con-
sensus in’ in the Delphi survey, but at the meeting sur-
geons did not reach consensus regarding including these
outcomes. Unplanned central venous catheter was felt to
be a complication (rather than an outcome), rare in the
context of uncomplicated appendicitis and a measure of
practice rather than treatment success. Blood loss was
felt not specific enough and surgeons proposed that it
was not important unless a transfusion was required. The
outcome was redefined to blood loss requiring transfu-
sion and a subsequent vote held, but this still did not
achieve ‘consensus in’. Surgeons also felt that major or
minor complications was too vague and could include too
© 2020 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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Complication of long list of outcomes
 Systematic reviews
 Qualitative interviews with patients and parents
 Study-Specific Advisory Group input
Study registration n= 195
 Patients (12–18 years) n= 15
 Parents of patients (5–18 years) n= 67
 Surgeons n= 113
  Paediatric n= 57
  General n= 56
Delphi round 1 n= 147; 40 outcomes presented
 Patients n= 11
 Parents of patients  n= 57
 Surgeons n= 79
  Paediatric n= 45
  General n= 34
Delphi round 2 n= 122; 43 outcomes presented
 Patients n= 3
 Parents of patients  n= 51
 Surgeons n= 68
  Paediatric n= 39
  General n= 29
Delphi round 3 n= 90; 43 outcomes presented
 Patients n= 3
 Parents of patients  n= 32
 Surgeons n= 55
  Paediatric n= 34
  General n= 21
Consensus meetings n= 28; 43 outcomes eligible for
discussion and revoting
Patient and parent consensus meeting n= 11
 Patients n= 2
 Parents n= 9
Surgeon consensus meeting n= 17
 Paediatric n= 10
 General n= 7
Two outcomes included in parent and
patient meeting
 Wound complication
 Patient stress/psychological distress




 (including interventional radiology
 procedure)*
 Bowel obstruction
 Readmission to hospital
 Death





Two outcomes included in
surgeon meeting
 Length of hospital stay
 Time away from full activity
*Reoperation was redefined to include interventional radiology procedure. †It is necessary to report antibiotic failure only in studies of non-operative
treatment.
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Table 1 Summary of stakeholder outcome ratings across Delphi rounds and final consensus on outcomes at consensus meetings
Delphi rounds Consensus meetings
No. of stakeholders who voted














Operating time 48 (34⋅3)† 39 (32⋅5)† 23 (26)† Excluded Excluded
Conversion to open operation 55 (41⋅0)† 56 (47⋅5)† 34 (39)† Excluded Excluded
Blood loss 85 (63⋅4)† 93 (78⋅8)* 67 (76)* Excluded Excluded
Wound infection 88 (60⋅7)† 76 (62⋅8)† 58 (65)† Included Included
Intra-abdominal abscess 124 (85⋅5)* 115 (96⋅6)* 84 (95)* Included Included
Wound complication 91 (63⋅6)† 77 (63⋅6)† 57 (64)† Excluded Included
Fever after treatment 68 (46⋅9)† 59 (48⋅8)† 36 (41)† Excluded Excluded
Blood markers of inflammation 57 (41⋅9)† 54 (45⋅8)† 29 (33)† Excluded Excluded
Other infectious complication 59 (42⋅8)† 53 (44⋅9)† 29 (33)† Excluded Excluded
Duration of antibiotics 47 (33⋅1)† 35 (29⋅4)† 14 (16)† Excluded Excluded
Recovery of bowel function 51 (35⋅7)† 43 (35⋅8)† 22 (25)† Excluded Excluded
Time to ambulation 60 (42⋅9)† 49 (41⋅2)† 27 (30)† Excluded Excluded
Length of hospital stay 70 (47⋅9)† 54 (45⋅0)† 48 (54)† Included Excluded
Duration of drainage 49 (40⋅5)† 53 (47⋅7)† 38 (46)† Excluded Excluded
Unplanned CT 40 (30⋅5)† 35 (30⋅2)† 25 (29)† Excluded Excluded
Any unplanned imaging 32 (24⋅1)† 25 (21⋅4)† 15 (18)† Excluded Excluded
Interventional radiology procedure 53 (44⋅5)† 73 (64⋅6)† 59 (69)* Excluded‡ Excluded
Unplanned central venous catheter 56 (46⋅3)† 73 (64⋅0)† 64 (74)* Excluded Excluded
Reoperation 97 (74⋅6)* 109 (93⋅2)* 81 (94)* Included‡ Included
Antibiotic failure§ 79 (59⋅0)† 82 (71⋅3)* 64 (76)* Included Included
Analgesia 45 (31⋅5)† 43 (36⋅1)† 25 (29)† Excluded Excluded
Pain score 66 (45⋅5)† 58 (48⋅7)† 44 (51)† Excluded Excluded
Readmission to hospital 101 (71⋅1)* 102 (86⋅4)* 75 (88)* Included Included
Bowel obstruction 120 (86⋅3)* 111 (94⋅1)* 81 (94)* Included Included
Recurrent appendicitis 111 (81⋅0)* 105 (89⋅7)* 79 (92)* Included Included
Major or minor complication 94 (68⋅1)† 100 (84⋅7)* 78 (91)* Excluded Excluded
Death 124 (87⋅9)* 112 (94⋅9)* 81 (95)* Included Included
Time away from school 62 (43⋅1)† 54 (45⋅8)† 37 (43)† Excluded Excluded
Time away from full activity 40 (28⋅7)† 28 (23⋅7)† 15 (17)† Included Excluded
Parent time off work 34 (23⋅6)† 32 (27⋅1)† 16 (19)† Excluded Excluded
Wound healing time 41 (28⋅5)† 37 (31⋅4)† 23 (27)† Excluded Excluded
Child’s quality of life 96 (66)† 100 (84⋅0)* 82 (94)* Included Included
Cosmesis 32 (25)† 30 (26⋅5)† 22 (26)† Excluded Excluded
Parental stress 41 (28)† 34 (28⋅8)† 17 (20)† Excluded Excluded
Patient stress 76 (52)† 72 (60⋅5)† 59 (66)† Excluded Included‡
Total cost of treatment 38 (28)† 27 (23⋅1)† 14 (16)† Excluded Excluded
Cost-effectiveness 57 (42)† 49 (41⋅5)† 35 (41)† Excluded Excluded
Total healthcare visits 37 (27)† 29 (25⋅0)† 16 (19)† Excluded Excluded
Duration of home healthcare 25 (19)† 11 (9⋅5)† 5 (6)† Excluded Excluded
Bacterial peritoneal cultures 36 (29)† 33 (29⋅2)† 23 (28)† Excluded Excluded
Psychological distress¶ – 52 (44⋅4)† 37 (43)† Excluded Included‡
Negative appendicectomy¶ – 41 (37⋅6)† 29 (35)† Included Included
Time to normal diet¶ – 25 (21⋅0)† 12 (14)† Excluded Excluded
Values in parentheses are percentage of stakeholders who scored the item. *Consensus in; †no consensus. ‡Item combined with another item in the final
core outcome set. §It is necessary to report antibiotic failure only in studies of non-operative treatment. ¶Outcome introduced in round 2.
© 2020 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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OMERACT, Outcome Measures in Rheumatology.
many things for it to be meaningfully included in a core
outcome set.
Two other outcomes were discussed by surgeons. It
was proposed and agreed that interventional radiology
procedure should be combined with reoperation, another
outcome that achieved ‘consensus in’, because in a child
they would both be procedures under general anaesthesia.
Other infectious complication was discussed further with
reference to the implications that this complication could
have. Surgeons felt that an infectious complication would
be deemed as critically important if it resulted in reopera-
tion, but less important if it did not. They therefore agreed
that other infectious complication should not be included
in the core outcome set, because reoperation had already
achieved ‘consensus in’.
In total, surgeons agreed to include 12 outcomes in
the core outcome set: intra-abdominal abscess, reopera-
tion (including interventional radiology procedure), bowel
obstruction, readmission to hospital, death, child’s quality
of life, recurrent appendicitis, antibiotic failure (in stud-
ies examining non-operative treatment), wound infection,
length of hospital stay, negative appendicectomy, and time
away from full activity.
Patient and parent consensus meeting
In addition to the seven parents and one patient who
had completed the third round of the Delphi survey,
three further stakeholders attended. One was a patient
(identified via a parent) who matched the study eligibility
criteria but had not completed any of the previous Del-
phi surveys. The other two were parents who wished to
accompany their respective partners to the meeting. These
additional stakeholders reported completing the Delphi
surveys alongside their partner. The study team dis-
cussed these cases, and agreed that the additional patient
and two parents could attend the meeting to increase
patient and parent representation in the core outcome set
development.
Again, during the meeting, several outcomes warranted
extended discussion and/or a second vote. In round 3 of the
Delphi survey, patients and parents did not reach consensus
regarding inclusion of psychological distress, and parents
were not in consensus about inclusion of negative appen-
dicectomy; however, in the meeting, patients and parents
reached consensus to include both outcomes. Patient stress
achieved ‘consensus in’, and with one additional vote psy-
chological distress would also have achieved ‘consensus
in’. Following discussion, it was agreed to include patient
stress/psychological distress as a combined outcome in the
final core outcome set.
In Delphi round 3, patients and parents reached consen-
sus to include major or minor complications, pain score
and fever after treatment, and parents were in consensus to
include blood loss. However, patients and parents did not
reach consensus regarding inclusion of any of these out-
comes following discussion at the meeting. Pain score and
fever after treatment were not felt to be critically impor-
tant, and participants agreed that the importance of blood
loss would depend on the amount of blood lost and its
effect. Parents and patients suggested that the important
aspect of major or minor complications was the need to
capture a major complication but that a minor complica-
tion was less important. As key major complications, such
as intra-abdominal abscess and bowel obstruction, were
already included there was agreement not to include major
or minor complications.
In total, parents and patients agreed to include 12 out-
comes in the core outcome set: intra-abdominal abscess,
reoperation (including interventional radiology proce-
dure), bowel obstruction, readmission to hospital, death,
child’s quality of life, recurrent appendicitis, antibiotic
failure (although it was suggested to include this only
in studies examining non-operative treatment), wound
infection, wound complication, negative appendicectomy,
and patient stress/psychological distress.
Finalizing the core outcome set
Combining the surgeon and patient and parent out-
come sets resulted in a final core outcome set of 14
outcomes, including antibiotic failure, which needs to be
measured and reported only in studies of non-operative
treatment (Fig. 1). The outcomes were aligned with
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2.018 domains (Fig. 2).
Discussion
The final core outcome set includes 14 outcomes. Further
work is necessary, following COSMIN (COnsensus-based
Standards for the selection of health Measurement Instru-
ments) to define and measure the core outcomes19, for
example selection of the appropriate measure for child’s
quality of life.
One of the strengths of the study was the inclusion of
children, young people and parent stakeholders to ensure
that important outcomes were considered and included
that might otherwise be overlooked20. Although adult
patients have been increasingly included in the develop-
ment of core outcome sets3, few studies of core outcome
sets have included both children and parents as stakehold-
ers. Of those that have21,22, the degree to which children
and parents have been able to contribute their views on
which outcomes are important at all stages of the consen-
sus process has varied. Engaging these important stake-
holders in the development of the present core outcome
set and maintaining their engagement was challenging. To
an extent, the study team anticipated this; young people
and parents from the SSAG were consulted in advance to
inform study materials, and methods adjusted to optimize
engagement. Despite this, the proportion of young peo-
ple and parents who registered and engaged in all stages of
the study was lower than anticipated. When this was dis-
cussed with families, they indicated that, having recovered
from appendicitis, patients and parents had moved on with
their lives such that appendicitis was often something that
had been forgotten. Furthermore, as uncomplicated appen-
dicitis is an acute condition and the extent of involvement
of health professionals from various disciplines is arguably
more limited than for chronic conditions, the study team
did not include an expansive range of health professional
stakeholder panels. The focus was primarily on those likely
to be most affected (young people and parents) and those
who typically determine treatment decisions (surgeons).
Previous studies23–25 have adopted a similar approach, but
it is acknowledged that methods may have been strength-
ened by including a broader range of health professional
stakeholder roles.
A potential limitation of this study is that it was con-
ducted in the UK only. Although this strengthens the valid-
ity of the core outcome set for future UK-based research,
international ratification or validation of the core out-
come set should take place before adoption in other coun-
tries. Researchers planning to use this core outcome set in
other geographical areas should determine its applicabil-
ity to their research setting by using critical appraisal tools,
such as COS-STAD (Core Outcome Set – STAndards for
Development)5. A protocol for an international core out-
come set for treatment of uncomplicated appendicitis in
children has been published recently26.
Having developed a core outcome set for studies in
uncomplicated acute appendicitis in children and young
people using robust consensus methods, the surgical com-
munity should now adopt the core outcome set for future
studies. Such adoption will optimize the quality of research
in this field, and ensure that the outcomes measured are
clinically relevant to patients, parents and surgeons. Future
work is needed to agree how best the core outcomes should
be measured.
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Editor’s comments
BJS remains committed to improving the quality of clinical studies across surgery. Standardization of outcome
reporting is key in the drive to improve the quality of the surgical literature. In that regard, this paper is a step in
the right direction. Sherratt et al. have published a core outcome set (CoS) for young people with appendicitis. A
CoS is an agreed set of outcomes that should be measured and reported, as a minimum, in all clinical trials in specific
areas of health or healthcare1. The CoS methodology was developed using the COMET (Core Outcome Measures in
Effectiveness Trials) Initiative, which included input from patients as well as surgeons. A CoS enables comparison of the
important outcomes of interventions, improves the ability to perform meaningful systematic review and meta-analysis,
and provides reassurance that the outcomes being reported are the most important to surgeons and patients alike.
BJS anticipates CoS will become available for most common surgical conditions in the coming years. We have already
published CoS in breast reconstruction surgery and remain keen to publish others2. It will become standard for BJS
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